## BBY: Best Buy Co., Inc. - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.99 indicates fundamental undervaluation. Quality metrics strong (ROE 22%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($70.21)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Jump Financial LLC Grows Position in Best Buy Co., Inc. $BBY**
- Source: MarketBeat | 20251211T113633 | Neutral | Relevance: 99%
-  Jump Financial LLC significantly increased its holdings in Best Buy Co., Inc. (NYSE:BBY) by 356.2% in the second quarter, now owning 57,027 shares valued at $3.83 million. Other institutional investors also adjusted their positions in Best Buy, while company insiders sold 1.53 million shares worth over $126 million. Analysts maintain a "Hold" rating on Best Buy, with a consensus target price of $84.47, and the company recently declared a quarterly dividend of $0.95 per share.

**2. Best Buy offers deals, services for late holiday shoppers**
- Source: Chain Store Age | 20251210T162443 | Bullish | Relevance: 99%
-  Best Buy is targeting last-minute holiday shoppers with a variety of deals, services, and extended policies. These include an Apple sales event, multi-day sales, Friday doorbusters, and flexible delivery and pickup options. The retailer is also offering price matching, extended return periods, gift idea pages, an AI gift finder, and in-store showcases to enhance the shopping experience.

**3. Best Buy appoints lululemon CFO Meghan Frank to board of directors**
- Source: Investing.com | 20251209T090500 | Somewhat-Bullish | Relevance: 99%
- Best Buy Co., Inc. has appointed Meghan Frank, CFO of lululemon, to its Board of Directors, effective immediately. Frank brings over 20 years of experience in finance, merchandise planning, and retail, which is expected to be a key addition to Best Buy's governance structure as it adapts its retail strategy. This appointment follows Best Buy's strong financial performance, including a notable increase in second-quarter comparable sales and consistent dividend payments.

**4. Telsey Advisory Highlights Best Buyâ€™s (BBY) Strength in Consumer Electronics Market**
- Source: Insider Monkey | 20251209T203800 | Bullish | Relevance: 99%
- Telsey Advisory has increased its price target for Best Buy (NYSE:BBY) to $95, maintaining an Outperform rating due to the company's strong execution and growing market share in consumer electronics. Best Buy reported robust Q3 earnings, with comparable sales up 2.7% and EPS exceeding expectations, driven by strong performance in computing, gaming, and mobile phones. The company also announced a quarterly dividend of $0.95 per share, continuing its 12-year streak of increased payouts.

**5. Telsey Advisory Highlights Best Buy's (BBY) Strength in Consumer Electronics Market**
- Source: Finviz | 20251209T203800 | Bullish | Relevance: 99%
-  Telsey Advisory has raised its price target for Best Buy Co., Inc. (BBY) to $95 from $90, maintaining an Outperform rating due to the company's strong execution and growing market share in consumer electronics. Best Buy reported robust quarterly earnings with comparable sales growth of 2.7% and anticipates continued growth in computing and mobile phones. The company also announced a quarterly dividend of $0.95 per share, marking 12 consecutive years of increased payouts.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 7, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Evercore ISI Gr | $80 | $85 | -6% |
| 2025-11-26 | Truist Securiti | $84 | $79 | +6% |
| 2025-11-26 | Barclays | $81 | $74 | +9% |
| 2025-11-26 | UBS | $96 | $93 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Evercore ISI Gr | main | In-Line |
| 2025-11-26 | Truist Securiti | main | Hold |
| 2025-11-26 | Barclays | main | Equal-Weight |
| 2025-11-26 | UBS | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 8 ($101.97M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Blackrock Inc.: 11.8% (-0.5%)
- Vanguard Group Inc: 11.4% (+2.4%)
- State Street Corpora: 6.3% (-2.2%)
- JPMORGAN CHASE & CO: 4.5% (+74.1%)
- Charles Schwab Inves: 3.5% (+3.6%)

### Key Risks

1. Heavy insider selling: $102M sold (8 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 7 raises (avg +7%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.99 indicates undervaluation relative to growth. Quality metrics strong (ROE 22%). Analyst sentiment positive (7 raises, avg +7%). Insider selling cluster ($102.0M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $15.8B |
| Beta | 1.39 |
| 52W Range | $54.99 - $91.68 |
| Short Interest | 7.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.99 |
| Forward P/E | 11.1 |
| Current P/E | 11.8 |
| YoY Growth | 6.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -5.2% to -2.9% (+2.3% in 5 days), confirming momentum buildup. Below STRENGTH zone by 6.9pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.6%) - potential reversal signal. Underperforming sector by 3.8pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.89% (CS: 24) | Weak |
| RSI_14 | 46.0 | Neutral |
| MACD Histogram | -0.19 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 1.032x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $74.97
- **Stop Loss:** $70.21 (6.3% risk)
- **Target:** $84.49 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 289
- **Position Value:** $21,666.33
- **Portfolio %:** 21.67%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-03-03 (Est: $2.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.31 | $1.40 | +6.7% |
| 2025Q3 | $1.22 | $1.28 | +4.5% |
| 2025Q2 | $1.10 | $1.15 | +5.0% |
| 2025Q1 | $2.41 | $2.58 | +7.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*